Your search returned 119 results.

Results
	101.	Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers. [electronic resource] by Sun, Qi-Zheng Lin, Gui-Feng Li, Lin-Li Jin, Xi-Ting Huang, Lu-Yi Zhang, Guo Yang, Wei Chen, Kai Xiang, Rong Chen, Chong Wei, Yu-Quan Lu, Guang-Wen Yang, Sheng-Yong Producer: 20170905 In: Journal of medicinal chemistry vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	102.	A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma. [electronic resource] by Zhong, Lei Fu, Xiao-Yu Zou, Chan Yang, Ling-Ling Zhou, Shu Yang, Jiao Tang, Yun Cheng, Chuan Li, Lin-Li Xiang, Rong Chen, Li-Juan Chen, Yu-Zong Wei, Yu-Quan Yang, Sheng-Yong Producer: 20141209 In: International journal of cancer vol. 135 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	103.	Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer. [electronic resource] by Zheng, Ming-Wu Zhang, Chun-Hui Chen, Kai Huang, Mei Li, Ya-Ping Lin, Wan-Ting Zhang, Rong-Jie Zhong, Lei Xiang, Rong Li, Lin-Li Liu, Xin-Yu Wei, Yu-Quan Yang, Sheng-Yong Producer: 20161213 In: Molecular cancer therapeutics vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	104.	Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations. [electronic resource] by Yang, Jiao Wang, Li-Jiao Liu, Jing-Jing Zhong, Lei Zheng, Ren-Lin Xu, Yong Ji, Pan Zhang, Chun-Hui Wang, Wen-Jing Lin, Xing-Dong Li, Lin-Li Wei, Yu-Quan Yang, Sheng-Yong Producer: 20130226 In: Journal of medicinal chemistry vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	105.	A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models. [electronic resource] by Zhang, Nannan Zhang, Guo Liu, Ning Lin, Wanting Ji, Sen Zheng, Mingwu Chen, Kai Liang, Xiao Li, Guobo Ma, Yu Zhu, Jun Niu, Ting Li, Lin-Li Li, Jiong Wei, Yu-Quan Yang, Sheng-Yong Publication details: Oncotarget Dec 2017 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	106.	Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer. [electronic resource] by Liu, Xuesha Pu, Wenchen He, Huaiyu Fan, Xin Zheng, Yuanyuan Zhou, Jian-Kang Ma, Rui He, Juan Zheng, Yuzhu Wu, Ke Zhao, Yun Yang, Sheng-Yong Wang, Chun Wei, Yu-Quan Wei, Xia-Wei Peng, Yong Producer: 20200528 In: Cancer letters vol. 458 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	107.	Accumulation of FLT3(+) CD11c (+) dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor. [electronic resource] by Yan, Heng-Xiu Li, Wei-Wei Zhang, Yan Wei, Xia-Wei Fu, Li-Xin Shen, Guo-Bo Yin, Tao Li, Xiu-Ying Shi, Hua-Shan Wan, Yang Zhang, Qing-Yin Li, Jiong Yang, Sheng-Yong Wei, Yu-Quan Producer: 20150609 In: Immunologic research vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	108.	Taking quinazoline as a general support-Nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3. [electronic resource] by Li, Wei-Wei Chen, Jin-Juan Zheng, Ren-Lin Zhang, Wen-Qin Cao, Zhi-Xing Yang, Ling-Ling Qing, Xiao-Yu Zhou, Liang-Xue Yang, Li Yu, Luo-Ding Chen, Li-Juan Wei, Yu-Quan Yang, Sheng-Yong Producer: 20100708 In: ChemMedChem vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	109.	Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: synthesis, preliminary structure-activity relationships, and in vitro biological evaluation. [electronic resource] by Zeng, Xiu-Xiu Zheng, Ren-Lin Zhou, Tian He, Hai-Yun Liu, Ji-Yan Zheng, Yu Tong, Ai-Ping Xiang, Ming-Li Song, Xiang-Rong Yang, Sheng-Yong Yu, Luo-Ting Wei, Yu-Quan Zhao, Ying-Lan Yang, Li Producer: 20110124 In: Bioorganic & medicinal chemistry letters vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	110.	Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model. [electronic resource] by Li, Guo-Bo Ma, Shuang Yang, Ling-Ling Ji, Sen Fang, Zhen Zhang, Guo Wang, Li-Jiao Zhong, Jie-Min Xiong, Yu Wang, Jiang-Hong Huang, Shen-Zhen Li, Lin-Li Xiang, Rong Niu, Dawen Chen, Ying-Chun Yang, Sheng-Yong Producer: 20170612 In: Journal of medicinal chemistry vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	111.	SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. [electronic resource] by Cao, Zhi-Xing Zheng, Ren-Lin Lin, Hong-Jun Luo, Shi-Dong Zhou, Yan Xu, You-Zhi Zeng, Xiu-Xiu Wang, Zhao Zhou, Li-Na Mao, Yong-Qiu Yang, Li Wei, Yu-Quan Yu, Luo-Ting Yang, Sheng-Yong Zhao, Ying-Lan Producer: 20111003 In: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	112.	SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivo. [electronic resource] by Pan, Youli Xu, Yong Feng, Shan Luo, Shidong Zheng, Renlin Yang, Jiao Wang, Lijiao Zhong, Lei Yang, Han-Yu Wang, Bing-Lin Yu, Yang Liu, Jingjing Cao, Zhixing Wang, Xiaoyan Ji, Pan Wang, Zerong Chen, Xin Zhang, Shuang Wei, Yu-Quan Yang, Sheng-Yong Producer: 20121016 In: Molecular cancer therapeutics vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	113.	Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis. [electronic resource] by Ye, Ting-Hong Yang, Fang-Fang Zhu, Yong-Xia Li, Ya-Li Lei, Qian Song, Xue-Jiao Xia, Yong Xiong, Ying Zhang, Li-Dan Wang, Ning-Yu Zhao, Li-Feng Gou, Hong-Feng Xie, Yong-Mei Yang, Sheng-Yong Yu, Luo-Ting Yang, Li Wei, Yu-Quan Producer: 20171026 In: Cell death & disease vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	114.	Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants. [electronic resource] by Yang, Jiao Chen, Kai Zhang, Guo Yang, Qiu-Yuan Li, Yue-Shan Huang, Shen-Zhen Wang, Yan-Lin Yang, Wei Jiang, Xiao-Juan Yan, Heng-Xiu Zhu, Jing-Qiang Xiang, Rong Luo, You-Fu Li, Wei-Min Wei, Yu-Quan Li, Lin-Li Yang, Sheng-Yong Producer: 20180101 In: European journal of medicinal chemistry vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	115.	Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis. [electronic resource] by Ye, Ting-Hong Yang, Fang-Fang Zhu, Yong-Xia Li, Ya-Li Lei, Qian Song, Xue-Jiao Xia, Yong Xiong, Ying Zhang, Li-Dan Wang, Ning-Yu Zhao, Li-Feng Gou, Hong-Feng Xie, Yong-Mei Yang, Sheng-Yong Yu, Luo-Ting Yang, Li Wei, Yu-Quan Publication details: Cell death & disease Sep 2019 In: Cell death & disease vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	116.	Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer. [electronic resource] by Zhang, Chun-Hui Zheng, Ming-Wu Li, Ya-Ping Lin, Xing-Dong Huang, Mei Zhong, Lei Li, Guo-Bo Zhang, Rong-Jie Lin, Wan-Ting Jiao, Yan Wu, Xiao-Ai Yang, Jiao Xiang, Rong Chen, Li-Juan Zhao, Ying-Lan Cheng, Wei Wei, Yu-Quan Yang, Sheng-Yong Producer: 20150806 In: Journal of medicinal chemistry vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	117.	From Lead to Drug Candidate: Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer. [electronic resource] by Zhang, Chun-Hui Chen, Kai Jiao, Yan Li, Lin-Li Li, Ya-Ping Zhang, Rong-Jie Zheng, Ming-Wu Zhong, Lei Huang, Shen-Zhen Song, Chun-Li Lin, Wan-Ting Yang, Jiao Xiang, Rong Peng, Bing Han, Jun-Hong Lu, Guang-Wen Wei, Yu-Quan Yang, Sheng-Yong Producer: 20170608 In: Journal of medicinal chemistry vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	118.	Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo. [electronic resource] by Li, Wei-Wei Wang, Xiao-Yan Zheng, Ren-Lin Yan, Heng-Xiu Cao, Zhi-Xing Zhong, Lei Wang, Ze-Rong Ji, Pan Yang, Ling-Ling Wang, Li-Jiao Xu, Yong Liu, Jing-Jing Yang, Jiao Zhang, Chun-Hui Ma, Shuang Feng, Shan Sun, Qi-Zheng Wei, Yu-Quan Yang, Sheng-Yong Producer: 20120717 In: Journal of medicinal chemistry vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	119.	Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agents. [electronic resource] by Wang, Ning-Yu Xu, Ying Zuo, Wei-Qiong Xiao, Kun-Jie Liu, Li Zeng, Xiu-Xiu You, Xin-Yu Zhang, Li-Dan Gao, Chao Liu, Zhi-Hao Ye, Ting-Hong Xia, Yong Xiong, Ying Song, Xue-Jiao Lei, Qian Peng, Cui-Ting Tang, Hong Yang, Sheng-Yong Wei, Yu-Quan Yu, Luo-Ting Producer: 20150526 In: Journal of medicinal chemistry vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6